{"id":"placebo-mometasone","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo mometasone is a control preparation used in clinical trials and research studies. It contains no active mometasone ingredient and produces therapeutic effects only through placebo response mechanisms. It is used as a comparator arm in studies evaluating the efficacy of active mometasone formulations.","oneSentence":"This is a placebo formulation with no active pharmacological mechanism.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:11.796Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control/comparator in clinical trials for allergic rhinitis or asthma (no therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT06164951","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia","status":"COMPLETED","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2023-11-10","conditions":"Achondroplasia","enrollment":114},{"nctId":"NCT05171816","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-24","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":110},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06454240","phase":"PHASE2","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-07-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":79},{"nctId":"NCT05776927","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Asthma","enrollment":304},{"nctId":"NCT03732820","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-10-31","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":895},{"nctId":"NCT04851964","phase":"PHASE3","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-04-22","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":416},{"nctId":"NCT04715542","phase":"PHASE3","title":"Stibium Metallicum Praeparatum 6x Versus Placebo in the Prevention of Paclitaxel-induced Peripheral Neurotoxicity","status":"NOT_YET_RECRUITING","sponsor":"University of Bern","startDate":"2026-08","conditions":"Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":120},{"nctId":"NCT07240376","phase":"NA","title":"Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-11-25","conditions":"Non-Allergic Rhinitis With Eosinophilia Syndrome","enrollment":90},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT02895100","phase":"PHASE2","title":"Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis","status":"TERMINATED","sponsor":"Protagonist Therapeutics, Inc.","startDate":"2016-12","conditions":"Ulcerative Colitis","enrollment":98},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT06436534","phase":"NA","title":"Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-24","conditions":"Rhinitis, Allergic","enrollment":50},{"nctId":"NCT03705793","phase":"PHASE4","title":"Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis","enrollment":53},{"nctId":"NCT05545072","phase":"PHASE3","title":"Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)","status":"TERMINATED","sponsor":"Emory University","startDate":"2023-10-26","conditions":"Allergic Fungal Rhinosinusitis","enrollment":5},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT06077019","phase":"NA","title":"Role of Lung Function for Exercise Capacity in Well-trained Individuals","status":"RECRUITING","sponsor":"Morten Hostrup, PhD","startDate":"2023-10-03","conditions":"Exercise Performance","enrollment":60},{"nctId":"NCT05902325","phase":"PHASE4","title":"Identifying Predictors Of Response To Mepolizumab In CRSwNP","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-10-03","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":36},{"nctId":"NCT04596189","phase":"PHASE4","title":"Dupilumab for Prevention of Recurrence of CRSwNP After ESS","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-05-25","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":30},{"nctId":"NCT00070707","phase":"PHASE4","title":"Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-03","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":188},{"nctId":"NCT00779545","phase":"PHASE2","title":"A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":455},{"nctId":"NCT00750750","phase":"PHASE2","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT00731185","phase":"PHASE3","title":"Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Nasal Polyps","enrollment":162},{"nctId":"NCT00783237","phase":"PHASE4","title":"Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Allergic Rhinitis","enrollment":340},{"nctId":"NCT00751075","phase":"PHASE3","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT01502371","phase":"PHASE2","title":"A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-25","conditions":"Asthma","enrollment":583},{"nctId":"NCT01135134","phase":"PHASE3","title":"Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":333},{"nctId":"NCT00359216","phase":"PHASE4","title":"The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Perennial Allergic Rhinitis, Obstructive Sleep Apnea, Sleep Disorder","enrollment":30},{"nctId":"NCT00521599","phase":"PHASE4","title":"A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Asthma","enrollment":672},{"nctId":"NCT01258803","phase":"PHASE2","title":"A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-12","conditions":"Asthma","enrollment":92},{"nctId":"NCT00383721","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1196},{"nctId":"NCT00394355","phase":"PHASE4","title":"Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":566},{"nctId":"NCT00599027","phase":"PHASE3","title":"An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05","conditions":"Allergic Rhinitis, Asthma","enrollment":51},{"nctId":"NCT00732381","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":351},{"nctId":"NCT00733005","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-07","conditions":"Allergic Rhinitis","enrollment":324},{"nctId":"NCT01386125","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06","conditions":"Nasal Polyps","enrollment":748},{"nctId":"NCT00423176","phase":"PHASE3","title":"The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"Sinusitis","enrollment":237},{"nctId":"NCT00383240","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":781},{"nctId":"NCT00383435","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1055},{"nctId":"NCT00378378","phase":"PHASE3","title":"Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07","conditions":"Nasal Polyps","enrollment":127},{"nctId":"NCT00552032","phase":"PHASE3","title":"Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-08-01","conditions":"Adenoids Hypertrophy","enrollment":132},{"nctId":"NCT00383552","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":746},{"nctId":"NCT00635882","phase":"PHASE2","title":"Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02","conditions":"Asthma, Airway Inflammation","enrollment":93},{"nctId":"NCT00552110","phase":"PHASE2","title":"Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Seasonal Allergic Rhinitis","enrollment":707},{"nctId":"NCT00666679","phase":"PHASE2","title":"Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05","conditions":"Asthma","enrollment":134},{"nctId":"NCT06126952","phase":"PHASE2","title":"Azelastine Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2023-10-30","conditions":"Seasonal Allergic Rhinitis","enrollment":84},{"nctId":"NCT06200766","phase":"PHASE3","title":"A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Zheng Liu ENT","startDate":"2023-08-25","conditions":"Seasonal Allergic Rhinitis","enrollment":640},{"nctId":"NCT04849390","phase":"PHASE2","title":"A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"EsoCap AG","startDate":"2021-06-29","conditions":"Eosinophilic Esophagitis","enrollment":43},{"nctId":"NCT00576069","phase":"","title":"Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma","status":"RECRUITING","sponsor":"Gelb, Arthur F., M.D.","startDate":"2007-10-25","conditions":"Asthma","enrollment":60},{"nctId":"NCT04499235","phase":"PHASE2","title":"A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid","status":"TERMINATED","sponsor":"Alkahest, Inc.","startDate":"2020-01-30","conditions":"Pemphigoid, Bullous","enrollment":6},{"nctId":"NCT04299438","phase":"PHASE3","title":"Propranolol Rescue of Prolonged Labor","status":"TERMINATED","sponsor":"Lisa Levine","startDate":"2020-07-14","conditions":"Pregnancy, Prolonged","enrollment":164},{"nctId":"NCT05311475","phase":"PHASE3","title":"Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sandoz","startDate":"2022-04-04","conditions":"Seasonal Allergic Rhinitis","enrollment":669},{"nctId":"NCT05912192","phase":"NA","title":"The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2022-02-24","conditions":"Allergic Rhinitis","enrollment":163},{"nctId":"NCT03758950","phase":"PHASE2","title":"Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2","status":"COMPLETED","sponsor":"Jeffrey Glassberg","startDate":"2018-11-29","conditions":"Sickle Cell Disease","enrollment":80},{"nctId":"NCT05578482","phase":"PHASE4","title":"Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis","status":"UNKNOWN","sponsor":"Jacob Pontoppidan Thyssen","startDate":"2022-10-24","conditions":"Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis Flare","enrollment":45},{"nctId":"NCT02874144","phase":"PHASE2","title":"Anti-Inflammatory Agent in Sinusitis","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-06-20","conditions":"Nasal Polyps","enrollment":43},{"nctId":"NCT03688555","phase":"PHASE2","title":"A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-10-19","conditions":"Bilateral Nasal Polyposis","enrollment":10},{"nctId":"NCT02573233","phase":"PHASE2","title":"Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-01-27","conditions":"Asthma","enrollment":42},{"nctId":"NCT00553891","phase":"PHASE4","title":"Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Nasal Obstruction, Adenoids Hypertrophy, Adenoidectomy","enrollment":""},{"nctId":"NCT01026870","phase":"PHASE3","title":"Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2012-06","conditions":"Asthma","enrollment":""},{"nctId":"NCT03855189","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1993-08-23","conditions":"Seasonal Allergic Rhinitis","enrollment":345},{"nctId":"NCT00453063","phase":"PHASE3","title":"Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-03","conditions":"Seasonal Allergic Rhinitis","enrollment":426},{"nctId":"NCT00468312","phase":"PHASE3","title":"Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-03","conditions":"Seasonal Allergic Rhinitis","enrollment":429},{"nctId":"NCT00442351","phase":"PHASE4","title":"Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":26},{"nctId":"NCT03882047","phase":"PHASE3","title":"Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-08-11","conditions":"Rhinitis, Allergic, Seasonal","enrollment":313},{"nctId":"NCT03861559","phase":"PHASE3","title":"Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-03-30","conditions":"Rhinitis, Allergic, Seasonal","enrollment":201},{"nctId":"NCT03879772","phase":"PHASE3","title":"Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-03-12","conditions":"Rhinitis, Allergic, Seasonal","enrollment":679},{"nctId":"NCT03855228","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1995-03-01","conditions":"Rhinitis, Allergic","enrollment":704},{"nctId":"NCT00491504","phase":"PHASE4","title":"This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02","conditions":"Seasonal Allergic Rhinitis","enrollment":310},{"nctId":"NCT00783224","phase":"PHASE3","title":"A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Perennial Allergic Rhinitis","enrollment":351},{"nctId":"NCT00728416","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":333},{"nctId":"NCT00358527","phase":"PHASE4","title":"Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Seasonal Allergic Rhinitis","enrollment":401},{"nctId":"NCT03614923","phase":"PHASE2","title":"Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","status":"COMPLETED","sponsor":"AnaptysBio, Inc.","startDate":"2018-11-29","conditions":"Chronic Rhinosinusitis","enrollment":105},{"nctId":"NCT01673659","phase":"PHASE3","title":"A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1220},{"nctId":"NCT03401229","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-01-15","conditions":"Nasal Polyposis","enrollment":413},{"nctId":"NCT03085797","phase":"PHASE3","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-25","conditions":"Nasal Polyps","enrollment":414},{"nctId":"NCT04915456","phase":"PHASE4","title":"Effect of Postoperative Additive Systemic Steroids in CRSwNP","status":"COMPLETED","sponsor":"Friedrich-Alexander-Universität Erlangen-Nürnberg","startDate":"2005-01-18","conditions":"Sinusitis, Chronic","enrollment":106},{"nctId":"NCT01038427","phase":"PHASE3","title":"A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sandoz","startDate":"2009-12-02","conditions":"Rhinitis, Allergic, Seasonal","enrollment":795},{"nctId":"NCT02628886","phase":"PHASE3","title":"Protecting From Pneumococcus in Early Life (The PROPEL Trial)","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2016-03-11","conditions":"Pneumonia","enrollment":600},{"nctId":"NCT02318303","phase":"PHASE2","title":"To Study GSP 301 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-12","conditions":"Seasonal Allergic Rhinitis","enrollment":1111},{"nctId":"NCT01850823","phase":"PHASE3","title":"Clinical Equivalence Study of Mometasone Nasal Spray","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2013-02","conditions":"Seasonal Allergic Rhinitis","enrollment":880},{"nctId":"NCT03280550","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-15","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":138},{"nctId":"NCT03280537","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-21","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":127},{"nctId":"NCT02709538","phase":"PHASE3","title":"Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-04","conditions":"Perennial Allergic Rhinitis","enrollment":601},{"nctId":"NCT01408901","phase":"NA","title":"Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2011-09","conditions":"Peripheral Arterial Disease","enrollment":210},{"nctId":"NCT02898454","phase":"PHASE3","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-28","conditions":"Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)","enrollment":448},{"nctId":"NCT03463031","phase":"PHASE3","title":"Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2018-03-16","conditions":"Seasonal Allergic Rhinitis (SAR)","enrollment":446},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT03011632","phase":"PHASE4","title":"Response of the Airway in Sinusitis and Asthma","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2017-01","conditions":"Sinusitis, Asthma","enrollment":150},{"nctId":"NCT02912468","phase":"PHASE3","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-12-05","conditions":"Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)","enrollment":276},{"nctId":"NCT02066298","phase":"PHASE3","title":"Steroids In Eosinophil Negative Asthma","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2014-07","conditions":"Asthma","enrollment":295},{"nctId":"NCT02061202","phase":"PHASE2","title":"Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease","status":"COMPLETED","sponsor":"Jeffrey Glassberg","startDate":"2014-03","conditions":"Sickle Cell Disease","enrollment":54},{"nctId":"NCT02113267","phase":"PHASE2","title":"Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.","status":"TERMINATED","sponsor":"Mogens Bove","startDate":"2014-04","conditions":"Eosinophilic Esophagitis","enrollment":40},{"nctId":"NCT02631551","phase":"PHASE3","title":"Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-03","conditions":"Seasonal Allergic Rhinitis","enrollment":1180},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT02870205","phase":"PHASE3","title":"Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-08","conditions":"Seasonal Allergic Rhinitis (SAR)","enrollment":1176},{"nctId":"NCT03449836","phase":"PHASE3","title":"Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2018-03-01","conditions":"Allergy","enrollment":60},{"nctId":"NCT01210170","phase":"NA","title":"Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma","status":"COMPLETED","sponsor":"University of Miami","startDate":"2010-10","conditions":"Asthma","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":281,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo"],"phase":"marketed","status":"active","brandName":"placebo mometasone","genericName":"placebo mometasone","companyName":"Medical University of Lodz","companyId":"medical-university-of-lodz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo formulation with no active pharmacological mechanism. Used for Control/comparator in clinical trials for allergic rhinitis or asthma (no therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}